21 May 2020
Pharma contract manufacturing in Italy located in worst-hit COVID-19 regions
By Staff Writer
Italy is a major active pharmaceutical ingredient (API) supplier to the global market, and its stringent lockdown measures have caused disruption of the supply chains that relied on this manufacture during lockdowns. While the country is now looking to reduce these restrictions, as the rate of COVID-19 infections has fallen and pressure from businesses and...
